For the purpose of reimbursing the costs of cross-border healthcare, this Directive should cover not only the situation where the patient is provided with healthcare in a Member State other than the Member State of affiliation, but also the prescription, dispensation and provision of medicinal products and medical devices where these are provided in the context of a health service. The definition of cross-border healthcare should cover both the situation in which a patient purchases such medicinal products and medical devices in a Member State other than the Member State of affiliation and the situation in which the patient purchases such medicinal products and medical devices in another Member State than that in which the prescription was issued.
Recital 16, Directive (EU) 2011/24
In forcesince 9 Mar 2011cited 1×
Judgment of the Court (Fifth Chamber) of 18 September 2019. VIPA Kereskedelmi és Szolgáltató Kft. v Országos Gyógyszerészeti és Élelmezés-egDecision
That interpretation, resulting from the context of Article 11(1), is supported by the objectives pursued by Directive 2011/24. According to Article 1(1) and (2) of that directive, read in the light of recitals 10 and 11 thereof, that …
18 Sep 2019 · 62018CJ0222